Now more than ever we can benefit from studies embedded in health-care systems to answer common clinical questions.
Led by Dr. Lisa A. Jackson, first-ever trial of any experimental vaccine candidate for COVID-19 virus has expanded.
On March 16, 4 volunteers received an injection of an mRNA vaccine for COVID-19 in NIH-funded trial in Seattle.
There’s much confusion about the new disease, but numbers don’t lie. The challenge is finding the right ones to follow.
CCHE is devising new ways to find the interventions that most benefit community health and how best to measure them.